Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Acalabrutinib
Study Purpose: This study was done to learn more about how
acalabrutinib acts in the blood in healthy
participants when given in different ways
Protocol Number: D8223C00005
Thank you!
Thank you for taking part in the clinical study for the study drug acalabrutinib.
AstraZeneca AB sponsored this study and believes it is important to share the
results. An independent non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1